XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health... Show more
XOMA is expected to report earnings to rise 624.25% to -28 cents per share on May 13
Q1'25
Est.
$-0.29
Q4'24
Beat
by $0.25
Q3'24
Missed
by $1.15
Q2'24
Beat
by $1.10
Q1'24
Missed
by $0.22
The last earnings report on March 17 showed earnings per share of -3 cents, beating the estimate of -28 cents. With 4.45K shares outstanding, the current market capitalization sits at 236.94M.